Medicure Inc V.MPH

MC1 delivers what causes this rare disease

[Checkout]

Intractable neonatal epileptic encephalopathy is characterized by the onset, shortly after birth, of drug-resistant seizures associated with severe neurological dysfunction.

Medicure Pharma has received orphan drug and rare pediatric disease designations from the U.S. Food and Drug Administration (FDA) for MC-1 for the treatment of PNPO deficiency.